-
Product Insights
King Cross Dev – Flora Sródmiescie Residential Complex – Lodz Voivodeship
The King Cross Dev – Flora Sródmiescie Residential Complex – Lodz Voivodeship project involved the construction of an 8500m2 eight-story residential complex comprising 162 apartments in Lodz Voivodeship, Poland. Equip yourself with the essential tools needed to make informed and profitable decisions with our King Cross Dev – Flora Sródmiescie Residential Complex – Lodz Voivodeship report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of...
-
Product Insights
Lower Crossing Wind Farm, US
Empower your strategies with our Lower Crossing Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a thorough understanding of the project’s core details and stages of development.. Monitor competitor...
-
Product Insights
Robinson Weeks – Charleston Global Crossing Warehouse – South Carolina
The Robinson Weeks – Charleston Global Crossing Warehouse – South Carolina involves the construction of a 59,023m2 warehouse on 19ha of land in North Charleston, South Carolina, the US. Equip yourself with the essential tools needed to make informed and profitable decisions with our Robinson Weeks – Charleston Global Crossing Warehouse – South Carolina report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the...
-
Product Insights
Decker Prop – Pioneer Crossing Commercial Center – Alberta
The Decker Prop – Pioneer Crossing Commercial Center – Alberta project involves the construction of a 1,709m2 commercial center in Alberta, Canada. Equip yourself with the essential tools needed to make informed and profitable decisions with our Decker Prop – Pioneer Crossing Commercial Center – Alberta report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NT-0796 in Atherosclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NT-0796 in Atherosclerosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NT-0796 in Atherosclerosis Drug Details: NT-0796 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NT-0796 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NT-0796 in Parkinson's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NT-0796 in Parkinson's Disease Drug Details: NT-0796 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NT-0796 in Inflammation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NT-0796 in Inflammation report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NT-0796 in Inflammation Drug Details: NT-0796 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Exlinkibart in Advanced Malignancy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Exlinkibart in Advanced Malignancy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Exlinkibart in Advanced Malignancy Drug Details: Exlinkibart (LVGN-6051) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MS-553 in Relapsed Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MS-553 in Relapsed Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MS-553 in Relapsed Chronic Lymphocytic Leukemia (CLL) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MS-553 in Refractory Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MS-553 in Refractory Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MS-553 in Refractory Chronic Lymphocytic Leukemia (CLL) Drug...